New Animal Drugs; Change of Sponsor's Name and Address, 3159 [2010-930]
Download as PDF
<![CDATA[
3159
Federal Register / Vol. 75, No. 12 / Wednesday, January 20, 2010 / Rules and Regulations
(8) Lead oxide in plasma display
panels (PDP) and surface conduction
electron emitter displays (SED) used in
structural elements; notably in the front
and rear glass dielectric layer, the bus
electrode, the black stripe, the address
electrode, the barrier ribs, the seal frit
and frit ring, as well as in print pastes.
(9) Lead oxide in the glass envelope
of Black Light Blue (BLB) lamps.
(e) Components of electronic devices
that are removable or replaceable, such
as battery packs and light bulbs that are
inaccessible when the product is
assembled in functional form or are
otherwise granted an exemption, are not
subject to the lead limits in paragraph
(a) of this section.
(f) Commission staff is directed to
reevaluate and report to the Commission
on the technological feasibility of
compliance with the lead limits in
paragraph (a) of this section for
children’s electronic devices, including
the technological feasibility of making
accessible component parts
inaccessible, and the status of the
exemptions, no less than every five
years after publication of a final rule in
the Federal Register on children’s
electronic devices.
Dated: January 12, 2010.
Todd A. Stevenson,
Secretary, Consumer Product Safety
Commission.
[FR Doc. 2010–877 Filed 1–19–10; 8:45 am]
BILLING CODE 6355–01–P
List of Subjects in 21 CFR Part 510
Administrative practice and
procedure, Animal drugs, Labeling,
Reporting and recordkeeping
requirements.
■ Therefore, under the Federal Food,
Drug, and Cosmetic Act and under
authority delegated to the Commissioner
of Food and Drugs and redelegated to
the Center for Veterinary Medicine, 21
CFR part 510 is amended as follows:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
[Docket No. FDA–2009–N–0665]
New Animal Drugs; Change of
Sponsor’s Name and Address
AGENCY:
Food and Drug Administration,
pwalker on DSK8KYBLC1PROD with RULES
Drug labeler
code
*
*
*
*
Fort Dodge Animal Health,
Division of Wyeth Holdings Corp., a wholly
owned subsidiary of
Pfizer, Inc., 235 East 42d
St., New York, NY 10017
Fort Dodge Animal Health,
Division of Wyeth, a
wholly owned subsidiary
of Pfizer, Inc., 235 East
42d St., New York, NY
10017
*
*
*
*
053501
000856
*
The Food and Drug
Administration (FDA) is amending the
animal drug regulations to reflect a
change of sponsor’s name from Fort
Dodge Animal Health, A Division of
Wyeth Holdings Corp. to Fort Dodge
Animal Health, Division of Wyeth
Holdings Corp., a wholly owned
subsidiary of Pfizer, Inc. In a separate
action, FDA is amending the animal
drug regulations to reflect a change of
sponsor’s name from Fort Dodge Animal
Health, Division of Wyeth to Fort Dodge
Animal Health, Division of Wyeth, a
Jkt 220001
*
(2) * * *
Drug labeler
code
*
Firm name and address
*
000856
*
*
*
Fort Dodge Animal Health,
Division of Wyeth, a
wholly owned subsidiary
of Pfizer, Inc., 235 East
42d St., New York, NY
10017
*
053501
*
*
*
*
*
Fort Dodge Animal Health,
Division of Wyeth Holdings Corp., a wholly
owned subsidiary of
Pfizer, Inc., 235 East 42d
St., New York, NY 10017
*
*
*
*
Dated: January 8, 2010.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug
Evaluation, Center for Veterinary Medicine.
[FR Doc. 2010–930 Filed 1–19–10; 8:45 am]
1. The authority citation for 21 CFR
part 510 continues to read as follows:
SUMMARY:
15:59 Jan 19, 2010
Firm name and address
PART 510—NEW ANIMAL DRUGS
DEPARTMENT OF THE TREASURY
Authority: 21 U.S.C. 321, 331, 351, 352,
353, 360b, 371, 379e.
Internal Revenue Service
2. In § 510.600, in the table in
paragraph (c)(1), revise the entries for
‘‘Fort Dodge Animal Health, A Division
of Wyeth Holdings Corp.’’ and ‘‘Fort
Dodge Animal Health, Division of
Wyeth’’; and in the table in paragraph
(c)(2), revise the entries for ‘‘000856’’
and ‘‘053501’’ to read as follows:
26 CFR Part 1
■
Final rule.
VerDate Nov<24>2008
(c) * * *
(1) * * *
BILLING CODE 4160–01–S
HHS.
ACTION:
wholly owned subsidiary of Pfizer, Inc.
In each case, the sponsor’s mailing
address will be changed.
DATES: This rule is effective January 20,
2010.
FOR FURTHER INFORMATION CONTACT:
David R. Newkirk, Center for Veterinary
Medicine (HFV–100), Food and Drug
Administration, 7520 Standish Pl.,
Rockville, MD 20855, 240–276–8307, email: david.newkirk@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Fort
Dodge Animal Health, A Division of
Wyeth Holdings Corp., P.O. Box 1339,
Fort Dodge, IA 50501 has informed FDA
of a change of name and mailing address
to Fort Dodge Animal Health, Division
of Wyeth Holdings Corp., a wholly
owned subsidiary of Pfizer, Inc., 235
East 42d St., New York, NY 10017. In
a separate action, Fort Dodge Animal
Health, Division of Wyeth, 800 Fifth St.
NW., Fort Dodge, IA 50501 has
informed FDA of a change of name and
mailing address to Fort Dodge Animal
Health, Division of Wyeth, a wholly
owned subsidiary of Pfizer, Inc., 235
East 42d St., New York, NY 10017.
Accordingly, the agency is amending
the regulations in 21 CFR 510.600(c) to
reflect these changes.
This rule does not meet the definition
of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because
it is a rule of ‘‘particular applicability.’’
Therefore, it is not subject to the
congressional review requirements in 5
U.S.C. 801–808.
■
§ 510.600 Names, addresses, and drug
labeler codes of sponsors of approved
applications.
*
PO 00000
*
*
Frm 00035
*
Fmt 4700
[TD 9475]
RIN 1545–BF83
Corporate Reorganizations;
Distributions Under Sections
368(a)(1)(D) and 354(b)(1)(B);
Correction
AGENCY: Internal Revenue Service (IRS),
Treasury.
*
Sfmt 4700
E:\FR\FM\20JAR1.SGM
20JAR1
]]>Agencies
[Federal Register Volume 75, Number 12 (Wednesday, January 20, 2010)]
[Rules and Regulations]
[Page 3159]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-930]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
[Docket No. FDA-2009-N-0665]
New Animal Drugs; Change of Sponsor's Name and Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor's name from Fort Dodge
Animal Health, A Division of Wyeth Holdings Corp. to Fort Dodge Animal
Health, Division of Wyeth Holdings Corp., a wholly owned subsidiary of
Pfizer, Inc. In a separate action, FDA is amending the animal drug
regulations to reflect a change of sponsor's name from Fort Dodge
Animal Health, Division of Wyeth to Fort Dodge Animal Health, Division
of Wyeth, a wholly owned subsidiary of Pfizer, Inc. In each case, the
sponsor's mailing address will be changed.
DATES: This rule is effective January 20, 2010.
FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for
Veterinary Medicine (HFV-100), Food and Drug Administration, 7520
Standish Pl., Rockville, MD 20855, 240-276-8307, e-mail:
david.newkirk@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Fort Dodge Animal Health, A Division of
Wyeth Holdings Corp., P.O. Box 1339, Fort Dodge, IA 50501 has informed
FDA of a change of name and mailing address to Fort Dodge Animal
Health, Division of Wyeth Holdings Corp., a wholly owned subsidiary of
Pfizer, Inc., 235 East 42d St., New York, NY 10017. In a separate
action, Fort Dodge Animal Health, Division of Wyeth, 800 Fifth St. NW.,
Fort Dodge, IA 50501 has informed FDA of a change of name and mailing
address to Fort Dodge Animal Health, Division of Wyeth, a wholly owned
subsidiary of Pfizer, Inc., 235 East 42d St., New York, NY 10017.
Accordingly, the agency is amending the regulations in 21 CFR
510.600(c) to reflect these changes.
This rule does not meet the definition of ``rule'' in 5 U.S.C.
804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements
in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
0
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
0
2. In Sec. 510.600, in the table in paragraph (c)(1), revise the
entries for ``Fort Dodge Animal Health, A Division of Wyeth Holdings
Corp.'' and ``Fort Dodge Animal Health, Division of Wyeth''; and in the
table in paragraph (c)(2), revise the entries for ``000856'' and
``053501'' to read as follows:
Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of
approved applications.
* * * * *
(c) * * *
(1) * * *
------------------------------------------------------------------------
Firm name and address Drug labeler code
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
Fort Dodge Animal Health, Division of Wyeth 053501
Holdings Corp., a wholly owned subsidiary
of Pfizer, Inc., 235 East 42d St., New
York, NY 10017
Fort Dodge Animal Health, Division of Wyeth, 000856
a wholly owned subsidiary of Pfizer, Inc.,
235 East 42d St., New York, NY 10017
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
(2) * * *
------------------------------------------------------------------------
Drug labeler code Firm name and address
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
000856 Fort Dodge Animal Health, Division of
Wyeth, a wholly owned subsidiary of
Pfizer, Inc., 235 East 42d St., New York,
NY 10017
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
053501 Fort Dodge Animal Health, Division of Wyeth
Holdings Corp., a wholly owned subsidiary
of Pfizer, Inc., 235 East 42d St., New
York, NY 10017
------------------------------------------------------------------------
* * * * *
------------------------------------------------------------------------
Dated: January 8, 2010.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 2010-930 Filed 1-19-10; 8:45 am]
BILLING CODE 4160-01-S
